These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25599171)

  • 1. A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.
    Shaw BE; Confer DL; Hwang W; Pulsipher MA
    Bone Marrow Transplant; 2015 Mar; 50(3):334-40. PubMed ID: 25599171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors.
    Pamphilon D; Nacheva E; Navarrete C; Madrigal A; Goldman J
    Transfusion; 2008 Jul; 48(7):1495-501. PubMed ID: 18373639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?
    Martino M; Fedele R; Massara E; Recchia AG; Irrera G; Morabito F
    Expert Opin Biol Ther; 2012 May; 12(5):609-21. PubMed ID: 22444029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
    Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
    Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and outcome in stem cell collections in HLA-haplo identical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Zeng DF; Wang QY
    Transfus Apher Sci; 2010 Aug; 43(1):23-8. PubMed ID: 20554478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
    Bennett CL; Evens AM; Andritsos LA; Balasubramanian L; Mai M; Fisher MJ; Kuzel TM; Angelotta C; McKoy JM; Vose JM; Bierman PJ; Kuter DJ; Trifilio SM; Devine SM; Tallman MS
    Br J Haematol; 2006 Dec; 135(5):642-50. PubMed ID: 17054431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
    de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
    Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
    Pulsipher MA; Nagler A; Iannone R; Nelson RM
    Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
    Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
    Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation.
    Cesaro S; Marson P; Gazzola MV; De Silvestro G; Destro R; Pillon M; Calore E; Messina C; Zanesco L
    Haematologica; 2002 Aug; 87(8 Suppl):35-41. PubMed ID: 12412388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of G-CSF to mobilise PBSC in normal healthy donors--an international survey.
    Cleaver SA; Goldman JM
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S29-31. PubMed ID: 9712489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the mobilization regimen and the harvesting technique on the granulocyte yield in healthy donors for granulocyte transfusion therapy.
    Ikemoto J; Yoshihara S; Fujioka T; Ohtsuka Y; Fujita N; Kokubunji A; Okamoto N; Ono J; Taniguchi K; Kaida K; Ikegame K; Okada M; Tanizawa T; Ogawa H; Kai S
    Transfusion; 2012 Dec; 52(12):2646-52. PubMed ID: 22519863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
    Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
    Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
    Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
    Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors.
    Leitner GC; Faschingbauer M; Wenda S; Weigel G; Fischer G
    Transfusion; 2014 Dec; 54(12):3121-6. PubMed ID: 24861153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.
    Vokurka S; Koza V; Jungova A; Navratilova J; Svoboda T; Jindra P; Steinerova K; Vyrutova R
    Bone Marrow Transplant; 2012 Jun; 47(6):867-8. PubMed ID: 21874056
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
    Heuft HG; Goudeva L; Blasczyk R
    Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.